IN2013MU02470A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02470A IN2013MU02470A IN2470MU2013A IN2013MU02470A IN 2013MU02470 A IN2013MU02470 A IN 2013MU02470A IN 2470MU2013 A IN2470MU2013 A IN 2470MU2013A IN 2013MU02470 A IN2013MU02470 A IN 2013MU02470A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (22)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2470MU2013 IN2013MU02470A (ru) | 2013-07-25 | 2013-07-25 | |
| TW103125304A TW201545773A (zh) | 2013-07-25 | 2014-07-24 | 包含降血脂劑的調合物 |
| BR112015031878A BR112015031878A2 (pt) | 2013-07-25 | 2014-07-24 | composição farmacêutica |
| EP14787059.6A EP3024446A1 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| EA201690072A EA201690072A1 (ru) | 2013-07-25 | 2014-07-24 | Состав, содержащий гиполипидемическое средство |
| MA38865A MA38865A1 (fr) | 2013-07-25 | 2014-07-24 | Formulation comprenant un agent hypolipidémiant |
| PCT/IN2014/000489 WO2015011730A1 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| SG11201509798PA SG11201509798PA (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| JP2016522969A JP2016523895A (ja) | 2013-07-25 | 2014-07-24 | 脂質低下剤を含む製剤 |
| US14/899,912 US9610277B2 (en) | 2013-07-25 | 2014-07-24 | Formula comprising a hypolipidemic agent |
| NZ714558A NZ714558A (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| KR1020157036380A KR101786843B1 (ko) | 2013-07-25 | 2014-07-24 | 지질 저하제를 포함하는 제제 |
| CA2917923A CA2917923A1 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| CN201480041453.7A CN105407873A (zh) | 2013-07-25 | 2014-07-24 | 包含降血脂剂的制剂 |
| MX2015016971A MX2015016971A (es) | 2013-07-25 | 2014-07-24 | Formulacion que comprende un agente hipolipidemico. |
| AU2014294548A AU2014294548B2 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
| ARP140102777A AR097067A1 (es) | 2013-07-25 | 2014-07-25 | Formulación que comprende un agente hipolipidémico |
| AP2015008876A AP2015008876A0 (en) | 2013-07-25 | 2015-07-24 | Formulation comprising a hypolipidemic agent |
| ZA2015/08682A ZA201508682B (en) | 2013-07-25 | 2015-11-25 | Formulation comprising a hypolipidemic agent |
| PH12015502802A PH12015502802A1 (en) | 2013-07-25 | 2015-12-17 | Formulation comprising a hypolipidemic agent |
| HK16107193.2A HK1219222A1 (zh) | 2013-07-25 | 2016-06-21 | 包含降血脂藥的製劑 |
| US15/475,812 US10098868B2 (en) | 2013-07-25 | 2017-03-31 | Formula comprising a hypolipidemic agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2470MU2013 IN2013MU02470A (ru) | 2013-07-25 | 2013-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02470A true IN2013MU02470A (ru) | 2015-06-26 |
Family
ID=51787141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2470MU2013 IN2013MU02470A (ru) | 2013-07-25 | 2013-07-25 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9610277B2 (ru) |
| EP (1) | EP3024446A1 (ru) |
| JP (1) | JP2016523895A (ru) |
| KR (1) | KR101786843B1 (ru) |
| CN (1) | CN105407873A (ru) |
| AP (1) | AP2015008876A0 (ru) |
| AR (1) | AR097067A1 (ru) |
| AU (1) | AU2014294548B2 (ru) |
| BR (1) | BR112015031878A2 (ru) |
| CA (1) | CA2917923A1 (ru) |
| EA (1) | EA201690072A1 (ru) |
| HK (1) | HK1219222A1 (ru) |
| IN (1) | IN2013MU02470A (ru) |
| MA (1) | MA38865A1 (ru) |
| MX (1) | MX2015016971A (ru) |
| NZ (1) | NZ714558A (ru) |
| PH (1) | PH12015502802A1 (ru) |
| SG (1) | SG11201509798PA (ru) |
| TW (1) | TW201545773A (ru) |
| WO (1) | WO2015011730A1 (ru) |
| ZA (1) | ZA201508682B (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101427486B (zh) | 2006-05-23 | 2013-06-19 | 英特尔公司 | 具有定向天线和一个或多个毫米波反射器的毫米波通信系统 |
| MY191100A (en) | 2011-01-31 | 2022-05-30 | Cadila Healthcare Ltd | Treatment for lipodystrophy |
| WO2014174524A1 (en) | 2013-04-22 | 2014-10-30 | Cadila Healthcare Limited | A novel composition for nonalcoholic fatty liver disease (nafld) |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (ru) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
| WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| KR101913830B1 (ko) * | 2016-12-05 | 2018-10-31 | 주식회사 코쿤디자인 | 기능성 led 어셈블리를 이용한 디스플레이 장치 |
| JP6840853B2 (ja) | 2016-12-09 | 2021-03-10 | カディラ・ヘルスケア・リミテッド | 原発性胆汁性胆管炎の治療 |
| EP3923932A4 (en) * | 2019-02-13 | 2022-11-16 | Cadila Healthcare Limited | TREATMENT OF POLYCYSTIC OVARY SYNDROME (PCOS) |
| US20220169603A1 (en) * | 2019-03-11 | 2022-06-02 | Cadila Healthcare Ltd. | Novel salts, crystalline forms and premix of hypolipidemic agent |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
| US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| RU2134686C1 (ru) | 1992-07-03 | 1999-08-20 | Смитклайн Бичам П.Л.С. | Гетероциклическое соединение, или его таутомерная форма, и/или фармацевтически приемлемая соль, и/или фармацевтически приемлемый сольват, фармацевтическая композиция, снижающая содержание глюкозы в крови, способ лечения и/или профилактики гипергликемии |
| GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| US5387613A (en) | 1993-07-23 | 1995-02-07 | Ribogene, Inc. | Treatment of tachyarrhythmias of supraventricular origin |
| GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
| WO1996004261A1 (en) | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
| ES2164241T3 (es) | 1995-04-28 | 2002-02-16 | Daiichi Seiyaku Co | Compuestos pentaciclicos. |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| CN1280574A (zh) | 1997-10-27 | 2001-01-17 | 雷迪研究基金会 | 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物 |
| WO1999019313A1 (en) | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| AU1120599A (en) | 1998-04-23 | 1999-03-08 | Dr. Reddy's Research Foundation | New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them |
| NZ504106A (en) | 1998-05-27 | 2003-02-28 | Dr | Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them |
| JP2002527503A (ja) | 1998-10-21 | 2002-08-27 | ノボ ノルディスク アクティーゼルスカブ | 新規化合物類、それらの調製及び使用 |
| WO2000023451A1 (en) | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| EP1123292A1 (en) | 1998-10-21 | 2001-08-16 | Novo Nordisk A/S | New compounds, their preparation and use |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| NZ520402A (en) | 2000-01-19 | 2006-04-28 | Cadila Healthcare Ltd | Novel compounds having hypolipedemic, hypocholesteremic activites, process for their preparation and pharmaceutical compositions containing them |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| WO2002024625A2 (en) | 2000-09-22 | 2002-03-28 | Dr. Reddy's Research Foundation | Process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| JP4745616B2 (ja) * | 2003-02-26 | 2011-08-10 | 武田薬品工業株式会社 | 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法 |
| WO2005031335A1 (ja) | 2003-09-26 | 2005-04-07 | Mitsubishi Rayon Co., Ltd. | 電気泳動装置および電気泳動法並びにそれを用いた生体関連物質の検出方法 |
| CN102127053A (zh) | 2004-03-15 | 2011-07-20 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
| DE602007009489D1 (de) * | 2006-02-22 | 2010-11-11 | Eisai R&D Man Co Ltd | Stabilisierte pharmazeutische zusammensetzung |
| WO2007122635A2 (en) | 2006-04-26 | 2007-11-01 | Astron Research Limited | Controlled release formulation comprising anti-epileptic drugs |
| JP5424571B2 (ja) * | 2007-04-12 | 2014-02-26 | 協和発酵キリン株式会社 | トピラマート含有固形製剤 |
| PT2641596T (pt) | 2009-11-26 | 2018-07-31 | Genfit | Utilização de derivados de 1,3-difenilprop-2-en-1-ona para tratamento de doenças hepáticas |
| BR112013008985A2 (pt) * | 2010-10-12 | 2016-07-05 | Cerecor Inc | composições antitussígenas compreendendo memantina |
| MY191100A (en) | 2011-01-31 | 2022-05-30 | Cadila Healthcare Ltd | Treatment for lipodystrophy |
| WO2014174524A1 (en) * | 2013-04-22 | 2014-10-30 | Cadila Healthcare Limited | A novel composition for nonalcoholic fatty liver disease (nafld) |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (ru) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| US9951009B2 (en) | 2013-08-29 | 2018-04-24 | Cadila Healthcare Limited | Polymorphic form of pyrrole derivative and intermediate thereof |
| WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
-
2013
- 2013-07-25 IN IN2470MU2013 patent/IN2013MU02470A/en unknown
-
2014
- 2014-07-24 NZ NZ714558A patent/NZ714558A/en not_active IP Right Cessation
- 2014-07-24 AU AU2014294548A patent/AU2014294548B2/en not_active Expired - Fee Related
- 2014-07-24 SG SG11201509798PA patent/SG11201509798PA/en unknown
- 2014-07-24 JP JP2016522969A patent/JP2016523895A/ja active Pending
- 2014-07-24 BR BR112015031878A patent/BR112015031878A2/pt not_active IP Right Cessation
- 2014-07-24 TW TW103125304A patent/TW201545773A/zh unknown
- 2014-07-24 MA MA38865A patent/MA38865A1/fr unknown
- 2014-07-24 WO PCT/IN2014/000489 patent/WO2015011730A1/en active Application Filing
- 2014-07-24 CN CN201480041453.7A patent/CN105407873A/zh active Pending
- 2014-07-24 KR KR1020157036380A patent/KR101786843B1/ko active IP Right Grant
- 2014-07-24 EA EA201690072A patent/EA201690072A1/ru unknown
- 2014-07-24 US US14/899,912 patent/US9610277B2/en active Active
- 2014-07-24 CA CA2917923A patent/CA2917923A1/en not_active Abandoned
- 2014-07-24 EP EP14787059.6A patent/EP3024446A1/en not_active Withdrawn
- 2014-07-24 MX MX2015016971A patent/MX2015016971A/es active IP Right Grant
- 2014-07-25 AR ARP140102777A patent/AR097067A1/es unknown
-
2015
- 2015-07-24 AP AP2015008876A patent/AP2015008876A0/xx unknown
- 2015-11-25 ZA ZA2015/08682A patent/ZA201508682B/en unknown
- 2015-12-17 PH PH12015502802A patent/PH12015502802A1/en unknown
-
2016
- 2016-06-21 HK HK16107193.2A patent/HK1219222A1/zh unknown
-
2017
- 2017-03-31 US US15/475,812 patent/US10098868B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TW201545773A (zh) | 2015-12-16 |
| AU2014294548B2 (en) | 2017-08-10 |
| US20160136131A1 (en) | 2016-05-19 |
| KR101786843B1 (ko) | 2017-10-18 |
| MX2015016971A (es) | 2016-04-25 |
| JP2016523895A (ja) | 2016-08-12 |
| KR20160013150A (ko) | 2016-02-03 |
| US9610277B2 (en) | 2017-04-04 |
| SG11201509798PA (en) | 2016-02-26 |
| US20170266158A1 (en) | 2017-09-21 |
| AU2014294548A1 (en) | 2015-12-17 |
| CA2917923A1 (en) | 2015-01-29 |
| EA201690072A1 (ru) | 2016-06-30 |
| CN105407873A (zh) | 2016-03-16 |
| EP3024446A1 (en) | 2016-06-01 |
| US10098868B2 (en) | 2018-10-16 |
| BR112015031878A2 (pt) | 2017-07-25 |
| ZA201508682B (en) | 2017-03-29 |
| AR097067A1 (es) | 2016-02-17 |
| NZ714558A (en) | 2017-02-24 |
| HK1219222A1 (zh) | 2017-03-31 |
| WO2015011730A1 (en) | 2015-01-29 |
| AP2015008876A0 (en) | 2015-11-30 |
| MA38865A1 (fr) | 2017-12-29 |
| PH12015502802A1 (en) | 2016-03-14 |